0

Journal Articles

in Genetics
 81-100 of 844 Articles
Original Contribution |  March 28, 2012 FREE
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor:  A Randomized Trial
Heikki Joensuu, MD; Mikael Eriksson, MD; Kirsten Sundby Hall, MD; et al.
JAMA. 2012;307(12):1265-1272. doi:10.1001/jama.2012.347.
Preliminary Communication |  March 28, 2012 FREE
Electrophysiological Study With Prophylactic Pacing and Survival in Adults With Myotonic Dystrophy and Conduction System Disease
Karim Wahbi, MD; Christophe Meune, MD; Raphaël Porcher, PhD; et al.
JAMA. 2012;307(12):1292-1301. doi:10.1001/jama.2012.346.
INCLUDES: , Supplemental Content
Preliminary Communication |  March 14, 2012 FREE
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung, MD, PhD; Jinghui Zhang, PhD; Charles Lu, PhD; et al.
JAMA. 2012;307(10):1062-1071. doi:10.1001/jama.2012.228.
INCLUDES: , Supplemental Content
Viewpoint |  March 14, 2012
Can Genomics Bend the Cost Curve?
Katrina Armstrong, MD, MS
JAMA. 2012;307(10):1031-1032. doi:10.1001/jama.2012.261.
Medical News and Perspectives |  February 08, 2012
NIH Program Helps Developers Navigate Path to New Drugs for Neglected Diseases
Rebecca Voelker
JAMA. 2012;307(6):549-550. doi:10.1001/jama.2012.83.
Viewpoint |  February 01, 2012
The Ethical Hazards and Programmatic Challenges of Genomic Newborn Screening
Aaron J. Goldenberg, PhD, MPH; Richard R. Sharp, PhD
JAMA. 2012;307(5):461-462. doi:10.1001/jama.2012.68.
Editorial |  January 25, 2012
Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
David M. Hyman, MD; David R. Spriggs, MD
JAMA. 2012;307(4):408-410. doi:10.1001/jama.2012.24.
Original Contribution |  January 25, 2012 FREE
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton, PhD; Georgia Chenevix- Trench, PhD; Cindy Goh, BA; et al.
JAMA. 2012;307(4):382-389. doi:10.1001/jama.2012.20.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  January 11, 2012
NIH Shifts Focus From Sequencing Genes to Fostering Clinical Applications
Bridget M. Kuehn
JAMA. 2012;307(2):132. doi:10.1001/jama.2011.1925.
Editorial |  January 04, 2012
The Debut of Viewpoints and Other New Developments at JAMA
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2012;307(1):90-91. doi:10.1001/jama.2011.1958.
Editorial |  December 28, 2011
Pharmacogenomics and Clopidogrel:  Irrational Exuberance?
Steven E. Nissen, MD
JAMA. 2011;306(24):2727-2728. doi:10.1001/jama.2011.1865.
Clinical Review |  December 28, 2011 FREE
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events:  A Systematic Review and Meta-analysis
Michael V. Holmes, MBBS, MSc; Pablo Perel, PhD; Tina Shah, PhD; et al.
JAMA. 2011;306(24):2704-2714. doi:10.1001/jama.2011.1880.
INCLUDES: CME , Supplemental Content
Global Health |  December 21, 2011
Genetic Susceptibility to Dengue
M. J. Friedrich
JAMA. 2011;306(23):2553. doi:10.1001/jama.2011.1809.
Original Contribution |  December 14, 2011 FREE
Cancer Risk Among Patients With Myotonic Muscular Dystrophy
Shahinaz M. Gadalla, MD, PhD; Marie Lund, MD; Ruth M. Pfeiffer, PhD; et al.
JAMA. 2011;306(22):2480-2486. doi:10.1001/jama.2011.1796.
INCLUDES: , Supplemental Content
JAMA Patient Page |  December 14, 2011 FREE
Muscular Dystrophy
Ann R. Punnoose, MD; Alison E. Burke, MA; Robert M. Golub, MD
JAMA. 2011;306(22):2526. doi:10.1001/jama.2011.1794.
INCLUDES: , Supplemental Content
Commentary |  December 07, 2011
Next-Generation DNA Sequencing, Regulation, and the Limits of Paternalism:  The Next Challenge
James P. Evans, MD, PhD; Jonathan S. Berg, MD, PhD
JAMA. 2011;306(21):2376-2377. doi:10.1001/jama.2011.1788.
Lab Reports |  December 07, 2011
Naked Mole Rat Genome
Tracy Hampton, PhD
JAMA. 2011;306(21):2315. doi:10.1001/jama.2011.1741.
Health Agencies Update |  November 23, 2011
Controversial Chelator Approved
Bridget M. Kuehn
JAMA. 2011;306(20):2207. doi:10.1001/jama.2011.1699.
Original Contribution |  November 23, 2011 FREE
Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
Jessica L. Mega, MD, MPH; Willibald Hochholzer, MD; Andrew L. Frelinger, PhD; et al.
JAMA. 2011;306(20):2221-2228. doi:10.1001/jama.2011.1703.
INCLUDES: , Supplemental Content
Lab, Field, and Clinic |  November 09, 2011
Knockout Science: Massive Mouse Project to Provide Window Into Human Diseases
Tracy Hampton, PhD
JAMA. 2011;306(18):1968. doi:10.1001/jama.2011.1625.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Phenotypic Conservation in Patients With X-Linked Retinitis Pigmentosa Caused by RPGR Mutations
Sarwar Zahid, MD, MS; Naheed Khan, PhD; Kari Branham, MS; et al.
JAMA Neurology
Original Contribution  |  May 13, 2013
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine, MD; Judy Qiang, BA; Emily Ashbridge; et al.
JAMA Neurology
Clinical Implications of Basic Neuroscience Research  |  May 13, 2013
TRIM Proteins in Therapeutic Membrane Repair of Muscular Dystrophy
Jenna Alloush; Noah Weisleder, PhD
JAMA Ophthalmology
Clinical Trials  |  May 9, 2013
Treatment With 9- cis β-Carotene–Rich Powder in Patients With Retinitis Pigmentosa:  A Randomized Crossover Trial
Ygal Rotenstreich, MD; Michael Belkin, MD; Siegal Sadetzki, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems